Advertisement

Medico-Legal Issues in Prenatal Genetic Diagnosis

  • Aubrey Milunsky

Abstract

The essential thrust and philosophy of prenatal genetic diagnosis is to provide the opportunity to parents at risk to selectively have unaffected offspring. Utilizing current indications for amniocentesis approximately 95% of all studies reveal an un-affected fetus (1, 2). The need to consider therapeutic abortion only arises in about 5% of cases. This emphasis focuses on the point that these studies secure the birth of children that would ordinarily not even have been born, in contrast to the probably smaller number in which abortion would be a considered option. The aim of prenatal studies is to detect serious or fatal genetic defect in the fetus, and not to determine carrier status. Indeed all of us are carriers of 4–8 deleterious genes, and any such goal would therefore be regarded as simply absurd.

Keywords

Prenatal Diagnosis Therapeutic Abortion Selective Abortion Amniotic Fluid Sample Healthy Fetus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Milunsky, A., “The Prenatal Diagnosis of Hereditary Disorders”, Charles C. Thomas, Springfield (1973).Google Scholar
  2. 2.
    Milunsky, A., “The Prevention of Mental Retardation and Genetic Disease”, W.B. Saunders Company, Philadelphia (1975).Google Scholar
  3. 3.
    Milunsky, A. and Reilly, P., Medico-legal issues in the prenatal diagnosis of hereditary disorders, Amer. J. Law Med. 1: 71 (1975).Google Scholar
  4. 4.
    Park v. Nissen, Cai. Super. Ct., Orange Co., Docket No. 190033, Dec. 13, 1974.Google Scholar
  5. 5.
    Doe v. Bolton, 410 U.S. 179, 192 (1973).Google Scholar
  6. 6.
    Friedman, J.M., Legal implications of amniocentesis, Univ. Penn. Law Rev. 123: 92 (1974).Google Scholar
  7. 7.
    Milunsky, A., Prenatal genetic diagnosis: risks and needs, in “Genetic Counseling”, H. Lubs and F. DeLa Cruz (eds.). Proceedings of a NIH Workshop, Denver, February 1975 (in press).Google Scholar
  8. 8.
    Ampola, M.G., Mahoney, M.J., Nakamura, E., Et al, In utero treatment of methylmalonic acidemia (MMA-EMIA) with vitamin B12, Pediat. Res. 8:113 (1974).Google Scholar
  9. 9.
    Roe v. Wade, 410 U.S. 113, (1973).Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Aubrey Milunsky
    • 1
    • 2
  1. 1.The Eunice Kennedy Shriver CenterHarvard Medical SchoolUSA
  2. 2.Massachusetts General HospitalUSA

Personalised recommendations